Medical News

RSS

Onyx enters commercialization agreement with Ono for carfilzomib and ONX 0912 development program

Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.

8 Sep 2010

Study finds multivitamins have no impact on cancer recurrence, survival

Patients with colon cancer who used multivitamins during and after being treated with post-surgical chemotherapy did not reduce the risk of the cancer returning or their dying from it, according to researchers at Dana-Farber Cancer Institute.

8 Sep 2010

PDS selected to migrate University of Utah Medical Group's data warehouse to EPIC system

University of Utah Medical Group (UUMG), a multispecialty academic medical group practice has selected Practical Data Solutions (PDS) to migrate their data warehouse and analytical reporting to the EPIC system which is scheduled to go live November 1st of this year.

8 Sep 2010

Dispensary of Hope adds seven new sites

The Dispensary of Hope, a Nashville-based not-for-profit social venture, is pleased to announce that seven new sites across the nation have been added to the Dispensary network, bringing the total number of sites to almost eighty. Apart from Tennessee, the locations of new sites include Pennsylvania, Michigan, Louisiana and Alabama, widening the scope of the Dispensary and providing opportunities to many different communities.

8 Sep 2010

Lack of sleep likely to develop diabetes, heart disease: Research

People who sleep less than six hours a night may be three times more likely to develop a condition which leads to diabetes and heart disease, according to researchers at the University of Warwick.

8 Sep 2010

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.

8 Sep 2010

Abbott completes acquisition of Piramal's Healthcare Solutions

Abbott has completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets.

8 Sep 2010

Children's Hospital Boston engages Particle Sciences for drug product development services

Particle Sciences Inc. (PSI), a leading pharmaceutical Contract Research Organization (CRO), has been engaged by Children's Hospital Boston to help advance early stage molecules and drug innovations into new therapeutic products for patient care. Under the established framework between Children's and PSI, Particle Sciences provides drug product development services aimed at progressing the specific drug or drug product candidate to the point where it becomes attractive to potential licensees.

8 Sep 2010

San Antonio podiatrist offers new MLS Therapy for pain management

Dr. Ed Davis, a podiatrist with offices in San Antonio, TX and Live Oak, TX, announces the immediate offering of a new form of laser therapy to patients in the San Antonio area. The addition is part of Dr. Davis' continued investment in advanced technologies and progressive procedures.

8 Sep 2010

A Republican win in November could put health law in center of political tug-of-war

The Associated Press looks at whether a Republican takeover of Congress would lead to an impasse with the White House over funding for implementation of the health law. "Republicans could still fall back on the congressional power of the purse, denying the administration billions of dollars to carry out the most far-reaching social legislation since Medicare and Medicaid.

8 Sep 2010

Study finds non-hormonal therapies can relieve hot flashes in women with breast cancer

Many women enduring hot flashes experience the heat, sweat and reddened upper body as an uncomfortable inconvenience. However, hot flashes can greatly diminish a woman's quality of life, disrupting sleep at night or causing embarrassment as she goes about her daily business. Many women enduring hot flashes experience the heat, sweat and reddened upper body as an uncomfortable inconvenience. However, hot flashes can greatly diminish a woman's quality of life, disrupting sleep at night or causing embarrassment as she goes about her daily business.

8 Sep 2010

NGP 555 compound effective in preventing amyloid pathology of Alzheimer's disease

In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.

8 Sep 2010

RTI Biologics, Zimmer ink global distribution agreement for dental biologic implants

RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, announced today the signing of an exclusive, 10-year distribution agreement with Zimmer Dental Inc. for biologic implants for the dental market worldwide.

8 Sep 2010

Researchers develop rapid screening test for mycotoxin detection

After close cooperation with researchers at the Norwegian Institute for Agricultural and Environmental Research (Bioforsk), Norwegian grain dealers are implementing a newly devised computational model and rapid screening tests to improve control of toxins in Norwegian cereals.

8 Sep 2010

Health law rollout effects: Delivering 'accountable' care, device tax, nursing mothers

Today's updates on the continuing implementation of the health law include Medicare chief Don Berwick's behind the scenes push for 'accountable care organizations,' tax anxiety in the medical device industry, and the promise of new help for pregnant women.

8 Sep 2010

Researchers discover tolerance mechanism in chronic morphine treatment

Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling.

8 Sep 2010

Quick increase of calcium concentration in cells rapidly trigger Aurora-A kinase enzyme activity

Aurora-A kinase (AurA) is an enzyme that is hyperactive in many cancers and drives tumor cell proliferation. Several AurA inhibitors are currently being tested in clinical trials to see if they slow tumor growth. Now, researchers in the Developmental Therapeutics Program at Fox Chase Cancer Center have identified an activation signal for AurA. They report in the September 7 issue of Nature Communications that a quick increase in the calcium concentration in a cell rapidly triggers AurA kinase activity.

8 Sep 2010

GW Cancer Institute receives grant to establish City-wide Patient Navigation Network in Washington

The GW Cancer Institute (GWCI) was recently awarded a $2.4 million grant from the D.C. Cancer Consortium to establish and coordinate a City-wide Patient Navigation Network (CPNN) in Washington, D.C.

8 Sep 2010

Few health insurance options for people with pre-existing conditions

The Los Angeles Times: "For people with preexisting medical conditions, looking for health insurance in the private market may feel like the ultimate fool's errand. … When the health reform law takes full effect in 2014, insurers will no longer be able to deny coverage to people with preexisting medical conditions. In the meantime, new federally funded high-risk pools for the medically uninsurable have been established. To qualify, you have to be without insurance for six months.

8 Sep 2010

K-State University receives patent for procedures to source stem cells from umbilical cord

Kansas State University has been a issued a patent for a plentiful and noncontroversial source of stem cells from a substance in the umbilical cord.

8 Sep 2010

Medical News

Onyx enters commercialization agreement with Ono for carfilzomib and ONX 0912 development program

Study finds multivitamins have no impact on cancer recurrence, survival

PDS selected to migrate University of Utah Medical Group's data warehouse to EPIC system

Dispensary of Hope adds seven new sites

Lack of sleep likely to develop diabetes, heart disease: Research

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Abbott completes acquisition of Piramal's Healthcare Solutions

Children's Hospital Boston engages Particle Sciences for drug product development services

San Antonio podiatrist offers new MLS Therapy for pain management

A Republican win in November could put health law in center of political tug-of-war

Study finds non-hormonal therapies can relieve hot flashes in women with breast cancer

NGP 555 compound effective in preventing amyloid pathology of Alzheimer's disease

RTI Biologics, Zimmer ink global distribution agreement for dental biologic implants

Researchers develop rapid screening test for mycotoxin detection

Health law rollout effects: Delivering 'accountable' care, device tax, nursing mothers

Researchers discover tolerance mechanism in chronic morphine treatment

Quick increase of calcium concentration in cells rapidly trigger Aurora-A kinase enzyme activity

GW Cancer Institute receives grant to establish City-wide Patient Navigation Network in Washington

Few health insurance options for people with pre-existing conditions

K-State University receives patent for procedures to source stem cells from umbilical cord

The importance of ketones from a clinical and medical perspective

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Latest News